News Headlines Article

Growing cancer drug developer snags first lease at massive Cove project
San Francisco Business Times

Cancer drug developer CytomX Therapeutics Inc. is claiming some of the first space at the The Cove at Oyster Point, HCP Inc.’s signature Peninsula development. The 76,153-square-foot, 10-year office and laboratory lease is significant because the high-profile Cove project at Highway 101 and Oyster Point Boulevard in South San Francisco is the first spec development of life sciences space on the Peninsula during the current biotech boom.